dimethyl sulfoxide, min 99.5%, for synthesis, 25 l, plastic packaging.

2-Fluoro-3,4-dimethoxybenzaldehyde, 97%, 250mg

2,3,5,6-Tetrafluorophenol, 97.0%, 500g

tert-Butyl (3-(dimethylamino)phenyl)carbamate, 95.0%, 1g

(Z)-METHYL 2-BROMOBUT-2-ENOATE, 95.0%, 250mg

Thalidomide-O-amido-C4-NH2 (TFA), 500mg

Methyl pyrazolo[1,5-a]pyridine-2-carboxylate, 98.0%, 100mg

Ethyl 4-(4-aminophenyl)butanoate hydrochloride, 98%, 500mg

10-(tert-Butoxy)-10-oxodecanoic acid, 95.0%, 1g

tert-Butyl 4-(2-(methylamino)ethyl)piperazine-1-carboxylate, 95.0%, 250mg

N,N-Dimethyloctanamide>98.0%(GC)5g

(R)-2-(4-Chlorophenyl)pyrrolidine hydrochloride, 95.0%, 1g

1,2,5-Trimethyl-pyrrolidine-2,5-dicarboxylic acid, 95.0%, 1g